Gains May Be On The Menu For Pfizer Inc. (NYSE: PFE)
Currently, there are 5.65B common shares owned by the public and among those 5.64B shares have been available to trade. Insiders at the company have transacted a total of 52 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Pfizer Inc. (NYSE: PFE): Hunting Genuine Value In Market Debris
Currently, there are 5.65B common shares owned by the public and among those 5.64B shares have been available to trade. Insiders at the company have transacted a total of 52 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Pfizer Inc. (NYSE: PFE) Seen Running Too Hot, Let’s Look At This More Closely
Insiders at the company have transacted a total of 52 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, accounting for 369,868 shares. Insider sales of the common stock occurred on 37 occasions, with total insider shares sold totaling […]
Analyst Expect Big Moves From Pfizer Inc. (NYSE: PFE)
Currently, there are 5.65B common shares owned by the public and among those 5.64B shares have been available to trade. Insiders at the company have transacted a total of 52 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
These Numbers Could Change Investor Views For Pfizer Inc. (NYSE: PFE)
Charles Schwab Investment Managem recently announced the acquisition of new stake in Pfizer Inc. (NYSE:PFE). The institutional investor has increased its shareholding in the Healthcare company by 10.88% to 95.77 million shares with purchase of 9.39 million shares. This fresh investment now brings its stake to 1.70% valued currently at $2.76 billion. In addition, Norges […]
Pfizer Inc. (PFE): A Great Stock For Handling Current Market Conditions?
Charles Schwab Investment Managem recently announced the acquisition of new stake in Pfizer Inc. (NYSE:PFE). The institutional investor has increased its shareholding in the Healthcare company by 10.88% to 95.77 million shares with purchase of 9.39 million shares. This fresh investment now brings its stake to 1.70% valued currently at $2.92 billion. In addition, Norges […]
Stick With Pfizer Inc. (PFE). The Bull Are Alive And Well
With over 30.07 million Pfizer Inc. (PFE) shares trading Friday and a closing price of $28.79 on the day, the dollar volume was approximately $865.72 million. Currently, there are 5.65B common shares owned by the public and among those 5.64B shares have been available to trade. An analysis of what Wall Street brokers have to […]
